An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.

@article{Diamond2006AnEO,
  title={An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.},
  author={Lisa E. Diamond and Dennis C. Earle and Julia R. Heiman and Raymond C. Rosen and Michael A. Perelman and Ronald Harning},
  journal={The journal of sexual medicine},
  year={2006},
  volume={3 4},
  pages={
          628-638
        }
}
INTRODUCTION Melanocortins affect multiple physiological responses, including sexual behaviors. Bremelanotide is a synthetic peptide melanocortin analog of alpha-melanocyte-stimulating hormone that is an agonist at melanocortin receptors MC3R and MC4R. AIM To evaluate a single intranasal dose of bremelanotide for potential effects on physiological and subjective measurements of sexual arousal and desire in premenopausal women with sexual arousal disorder. MAIN OUTCOME MEASURES Change in… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 31 CITATIONS

Bremelanotide: First Approval

VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 50 REFERENCES

The Sexual Tipping Point TM : A model to conceptualize etiology , diagnosis & combination treatment of female & male sexual dysfunction

L Hackbert, Heiman
  • J Sex Med
  • 2006

Psychosocial history

MA Perelman
  • UK: Taylor
  • 2005

Sex Med 2005;2(suppl 3):146–53

J concern
  • 2005